Drugs / recombinant 70-kD heat-shock protein
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00030303 | Jan 2001 → Jan 2004 | leukemia | UConn Health | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00005633 Background | Jun 1999 → Jun 2002 | cutaneous melanoma | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recombinant 70-kD heat-shock protein | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00005633 ↗ |
| Known as | HSP70 | “heat shock protein 70 (HSP70)” NCT00005633 ↗ |
| Modality | Protein / enzyme biologic | “heat shock protein 70 (HSP70)” NCT00005633 ↗ |
| Route | Subcutaneous | “subcutaneously” NCT00005633 ↗ |